Miromatrix Medical Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.00
Dividend & YieldN/A$ (N/A)
Beta N/A
Market capitalization 88.22M
Operating cash flow -27.23M
ESG Scores unknown

Company description

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Sector: Healthcare - Industry: Biotechnology

Financial Ratios
Quick Ratio12.12
Working Capital-0.29
Return On Equity-0.27
Debt To Equity0.01
Fixed Asset Ratio0.41
Fixed Interest Cover-25.07

Financial data

Financial Statements

Cashflow Statement 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -124.57k -467.6k 1.07M
Total Cashflows From Investing Activities 10.36M 2.88M -1.38M
Net Borrowings 249.84k 6.29M -35.2k
Total Cash From Financing Activities 312.34k 6.36M 65.36M
Change To Operating Activities -449.94k 1.49M 372.05k
Issuance Of Stock 62.5k 63.9k 45.5M
Net Income -4.05M -10.31M -14.67M
Change In Cash 2.35M 1.19M 49.17M
Effect Of Exchange Rate
Total Cash From Operating Activities -8.32M -8.04M -14.81M
Depreciation 344.13k 170.37k 167.91k
Change To Account Receivables 169.45k 42.17k
Other Cashflows From Financing Activities
Change To Netincome -4.34M 931.58k -1.81M
Capital Expenditures -101.45k -123.17k -3.38M

Income Statement 2019-12-31 2020-12-31 2021-12-31
Research Development 6.56M 7.55M 11.3M
Income Before Tax -5.03M -10.31M -14.67M
Net Income -4.05M -10.31M -14.67M
Selling General Administrative 2.44M 2.26M 5.19M
Gross Profit -453.47k -466.93k
Ebit -8.99M -10.26M -16.96M
Operating Income -8.99M -10.26M -16.96M
Interest Expense -48.38k -765.17k -676.52k
Income Tax Expense
Total Revenue 250k 46.53k 33.07k
Cost Of Revenue 250k 500k 500k
Total Other Income ExpenseNet 3.96M -51.02k 2.29M
Net Income From Continuing Ops -5.03M -10.31M -14.67M
Net Income Applicable To Common Shares -4.05M -10.31M -14.67M

Balance Sheet Statement 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 2.52M 9.63M 6.8M
Total Stockholder Equity -41.43M -51.03M 54.13M
Other Current Liabilities 246.96k 750.05k
Total Assets 7.75M 5.25M 60.93M
Common Stock 21 22 204
Other Current Assets 800.1k
Retained Earnings -49.07M -59.38M -74.05M
Treasury Stock
Cash 3.25M 4.44M 52.81M
Total Current Liabilities 1.62M 8.16M 4.56M
Other Stockholder Equity
Property, Plant, and Equipment 371.73k 324.53k 5.59M
Total Current Assets 3.87M 4.69M 55.34M
Net Tangible Assets -41.43M -51.03M 54.13M
Net Receivables 527.81k 115.2k 1.27M
Accounts Payable 302.98k 130.16k 2.09M


Insider Transactions

Here are the insider transactions of stock shares related to Miromatrix Medical Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
BUCKMAN PAUL RStock Award(Grant) at price 0.00 per share.I2022-08-10Director12.79k
ERB JOHN LStock Award(Grant) at price 0.00 per share.D2022-08-10Director12.79k
MAAG PETERStock Award(Grant) at price 0.00 per share.D2022-08-10Director12.79k
BURKE WILLIAM P.Stock Award(Grant) at price 0.00 per share.D2022-08-10Director12.79k
HEINE LISA WIPPERMANStock Award(Grant) at price 0.00 per share.D2022-08-10Director12.79k
ROSS JEFFREY JAMESConversion of Exercise of derivative security at price 1.25 per share.D2022-03-15Chief Executive Officer35.44k
NIEBUR BRIAN DStock Award(Grant) at price 0.00 per share.D2022-01-13Chief Financial Officer10k
ROSS JEFFREY JAMESStock Award(Grant) at price 0.00 per share.D2022-01-13Chief Executive Officer50k
KATTUNGAL LAJIStock Award(Grant) at price 0.00 per share.D2022-01-13Divisional Officer10k
BARRY JOHN JOSEPHStock Award(Grant) at price 0.00 per share.D2022-01-13Divisional Officer10k
BURKE WILLIAM P.Stock Award(Grant) at price 0.00 per share.D2022-01-03Director36.12k
HEINE LISA WIPPERMANStock Award(Grant) at price 0.00 per share.D2022-01-03Director36.12k
NIEBUR BRIAN DStock Award(Grant) at price 0.00 per share.D2021-10-01Chief Financial Officer8k
BARRY JOHN JOSEPHStock Award(Grant) at price 0.00 per share.D2021-10-01Officer10k
EIBENSTEINER RONALD ED/I2021-06-28Director199.77k
BUCKMAN PAUL RI2021-06-28Director3k
WAGNER MARK TD2021-06-28Director3.33k
NIEBUR BRIAN DD2021-06-28Chief Financial Officer6.67k
ERB JOHN LD2021-06-28Director6.67k
ROSS JEFFREY JAMESD2021-06-28Chief Executive Officer4.4k
ROSS JEFFREY JAMESD2021-06-28Chief Executive Officer4.4k
CHESHIRE MD HOLDINGS, L.L.C.I2021-06-28Beneficial Owner of more than 10% of a Class of Security1.98M
BAXTER INTERNATIONAL, INC.I2021-06-24Beneficial Owner of more than 10% of a Class of Security2.08M
BUCKMAN PAUL RD2021-06-23Director5.55k
ERB JOHN LD2021-06-23Director5.55k
MAAG PETERD2021-06-23Director22.22k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Miromatrix Medical Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Miromatrix Medical Inc

Here is the result of two systematic investment strategies applied to Miromatrix Medical Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Miromatrix Medical Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Miromatrix Medical Inc:

Miromatrix Medical Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -38.2% on the backtest period.

Performance at glance

Performance

-38.2 %

Latent gain

-97.52 $

Invested capital

255.3 $

Annualized return

-159.17 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Miromatrix Medical Inc

This is the result of two momentum investment strategies applied to Miromatrix Medical Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Miromatrix Medical Inc

The following chart shows all the entries opened by the momentum investment system on Miromatrix Medical Inc:

Miromatrix Medical Inc momentum entries
  • The first momentum investment strategy would give 0% of return on Miromatrix Medical Inc. That represents 0$ of latent gain with 0$ of employed capital.
  • The second momentum investment strategy would give 0% of return on Miromatrix Medical Inc. That represents 0$ of latent gain with 0$ of employed capital.
Performance at glance (1Q Momentum)

Performance

0 %

Latent gain

0 $

Invested capital

0 $

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

0 %

Latent gain

0 $

Invested capital

0 $

Annualized return

0 %

Momentum equity curve on Miromatrix Medical Inc

The following chart shows the equity curve of the two momentum strategies applied to Miromatrix Medical Inc:

Miromatrix Medical Inc momentum equity

Note: the dividends potentially given by Miromatrix Medical Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Miromatrix Medical Inc

The following chart shows the employed capital evolution of the two momentum strategies on Miromatrix Medical Inc since the beginning:

Miromatrix Medical Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Miromatrix Medical Inc

Buy the dip entry openings on Miromatrix Medical Inc

Miromatrix Medical Inc

The performance achieved by the robo-advisor on Miromatrix Medical Inc is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Miromatrix Medical Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Miromatrix Medical Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

-0.0 %

Equity curve of the strategy applied to Miromatrix Medical Inc

The following chart shows the result of the investment strategy applied to Miromatrix Medical Inc:

Miromatrix Medical Inc

Note: the dividends potentially given by Miromatrix Medical Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Miromatrix Medical Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Miromatrix Medical Inc:

Miromatrix Medical Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Miromatrix Medical Inc

In this section, I will compare the three previous investment strategies applied to Miromatrix Medical Inc.

Equity curve comparison on Miromatrix Medical Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Miromatrix Medical Inc investment strategy comparison

Employed capital comparison on Miromatrix Medical Inc

Miromatrix Medical Inc investment comparison

Performance comparison on Miromatrix Medical Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -38.2% -97.52$ 255.3$ -159.17%
Momentum 1 quarter 0% 0$ 0$ 0%
Momentum 2 quarters 0% 0$ 0$ 0%
Non-directional 0% 0.0$ 0.0$ -0.0%
Annualized return comparison

Automatic investment

-159.17 %

Momentum 1Q

0 %

Momentum 2Q

0 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Miromatrix Medical Inc:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Miromatrix Medical Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Miromatrix Medical Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Miromatrix Medical Inc
Country United States
City Eden Prairie
Address 6455 Flying Cloud Drive
Phone 952 942 6000
Website www.miromatrix.com
FullTime employees 61
Industry Biotechnology
Sector Healthcare
Exchange XNAS
Ticker MIRO
Market www.nasdaq.com

Miromatrix Medical Inc ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown